Silence Therapeutics (SLN) Receivables: 2019-2025
Historic Receivables for Silence Therapeutics (SLN) over the last 4 years, with Sep 2025 value amounting to $28,000.
- Silence Therapeutics' Receivables fell 92.52% to $28,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 91.42%. This contributed to the annual value of $972,000 for FY2024, which is 235.17% up from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Receivables is $28,000, which was down 67.06% from $85,000 recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Receivables ranged from a high of $15.4 million in Q2 2023 and a low of $28,000 during Q3 2025.
- Over the past 3 years, Silence Therapeutics' median Receivables value was $585,208 (recorded in 2023), while the average stood at $2.9 million.
- In the last 5 years, Silence Therapeutics' Receivables surged by 496.74% in 2022 and then slumped by 99.60% in 2025.
- Silence Therapeutics' Receivables (Quarterly) stood at $446,191 in 2021, then spiked by 140.53% to $1.1 million in 2022, then crashed by 72.98% to $290,000 in 2023, then spiked by 235.17% to $972,000 in 2024, then tumbled by 92.52% to $28,000 in 2025.
- Its Receivables was $28,000 in Q3 2025, compared to $85,000 in Q2 2025 and $41,000 in Q1 2025.